Results of the first year of the new liver allocation plan

Richard B. Freeman, Russell H. Wiesner, Erick Edwards, Ann Harper, Robert Merion, Robert Wolfe

Research output: Contribution to journalArticle

344 Citations (Scopus)

Abstract

Liver allocation policy in the U.S. was recently changed to a continuous disease severity scale with minimal weight given to time waiting in an effort to better prioritize deceased donor liver transplant candidates. We compared rates of waiting list registrations, removals, transplants, and deaths during the year prior to implementation of the new liver allocation policy (2/27/01-2/26/02, Era 1) with the first year's experience (2/27/02-2/26/03, Era 2) under this new policy. Rates were adjusted for 1,000 patient years on the waiting list and compared using z-tests. A 1-sided test was used to compare death rates; 2-sided tests were used to compare transplant rates. Overall and subgroup analyses were performed for demographic, geographic, and medical strata. In Era 2, we observed a 12% reduction in new liver transplant waiting list registrations, with the largest reductions seen in new registrants with low MELD/PELD scores. In Era 2, there was a 3.5% reduction in waiting list death rate (P = .076) and a 10.2% increase in cadaveric transplants (P < .001). The reduction in waiting list mortality and increase in transplantation rates were evenly distributed across all demographic and medical strata, with some variation across geographic variables. Early patient and graft survival after deceased donor liver transplantation remains unchanged. In conclusion, by eliminating the categorical waiting list prioritization system that emphasized time waiting, the new system has been associated with reduced registrations and improved transplantation rates without increased mortality rates for individual groups of waiting candidates or changes in early transplant survival rates.

Original languageEnglish (US)
Pages (from-to)7-15
Number of pages9
JournalLiver Transplantation
Volume10
Issue number1
DOIs
StatePublished - Jan 2004
Externally publishedYes

Fingerprint

Waiting Lists
Transplants
Liver
Mortality
Transplantation
Demography
Tissue Donors
Graft Survival
Liver Transplantation
Survival Rate
Weights and Measures

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Cite this

Freeman, R. B., Wiesner, R. H., Edwards, E., Harper, A., Merion, R., & Wolfe, R. (2004). Results of the first year of the new liver allocation plan. Liver Transplantation, 10(1), 7-15. https://doi.org/10.1002/lt.20024

Results of the first year of the new liver allocation plan. / Freeman, Richard B.; Wiesner, Russell H.; Edwards, Erick; Harper, Ann; Merion, Robert; Wolfe, Robert.

In: Liver Transplantation, Vol. 10, No. 1, 01.2004, p. 7-15.

Research output: Contribution to journalArticle

Freeman, RB, Wiesner, RH, Edwards, E, Harper, A, Merion, R & Wolfe, R 2004, 'Results of the first year of the new liver allocation plan', Liver Transplantation, vol. 10, no. 1, pp. 7-15. https://doi.org/10.1002/lt.20024
Freeman RB, Wiesner RH, Edwards E, Harper A, Merion R, Wolfe R. Results of the first year of the new liver allocation plan. Liver Transplantation. 2004 Jan;10(1):7-15. https://doi.org/10.1002/lt.20024
Freeman, Richard B. ; Wiesner, Russell H. ; Edwards, Erick ; Harper, Ann ; Merion, Robert ; Wolfe, Robert. / Results of the first year of the new liver allocation plan. In: Liver Transplantation. 2004 ; Vol. 10, No. 1. pp. 7-15.
@article{d39855b720e5483e8ceb06efa814b9c7,
title = "Results of the first year of the new liver allocation plan",
abstract = "Liver allocation policy in the U.S. was recently changed to a continuous disease severity scale with minimal weight given to time waiting in an effort to better prioritize deceased donor liver transplant candidates. We compared rates of waiting list registrations, removals, transplants, and deaths during the year prior to implementation of the new liver allocation policy (2/27/01-2/26/02, Era 1) with the first year's experience (2/27/02-2/26/03, Era 2) under this new policy. Rates were adjusted for 1,000 patient years on the waiting list and compared using z-tests. A 1-sided test was used to compare death rates; 2-sided tests were used to compare transplant rates. Overall and subgroup analyses were performed for demographic, geographic, and medical strata. In Era 2, we observed a 12{\%} reduction in new liver transplant waiting list registrations, with the largest reductions seen in new registrants with low MELD/PELD scores. In Era 2, there was a 3.5{\%} reduction in waiting list death rate (P = .076) and a 10.2{\%} increase in cadaveric transplants (P < .001). The reduction in waiting list mortality and increase in transplantation rates were evenly distributed across all demographic and medical strata, with some variation across geographic variables. Early patient and graft survival after deceased donor liver transplantation remains unchanged. In conclusion, by eliminating the categorical waiting list prioritization system that emphasized time waiting, the new system has been associated with reduced registrations and improved transplantation rates without increased mortality rates for individual groups of waiting candidates or changes in early transplant survival rates.",
author = "Freeman, {Richard B.} and Wiesner, {Russell H.} and Erick Edwards and Ann Harper and Robert Merion and Robert Wolfe",
year = "2004",
month = "1",
doi = "10.1002/lt.20024",
language = "English (US)",
volume = "10",
pages = "7--15",
journal = "Liver Transplantation",
issn = "1527-6465",
publisher = "John Wiley and Sons Ltd",
number = "1",

}

TY - JOUR

T1 - Results of the first year of the new liver allocation plan

AU - Freeman, Richard B.

AU - Wiesner, Russell H.

AU - Edwards, Erick

AU - Harper, Ann

AU - Merion, Robert

AU - Wolfe, Robert

PY - 2004/1

Y1 - 2004/1

N2 - Liver allocation policy in the U.S. was recently changed to a continuous disease severity scale with minimal weight given to time waiting in an effort to better prioritize deceased donor liver transplant candidates. We compared rates of waiting list registrations, removals, transplants, and deaths during the year prior to implementation of the new liver allocation policy (2/27/01-2/26/02, Era 1) with the first year's experience (2/27/02-2/26/03, Era 2) under this new policy. Rates were adjusted for 1,000 patient years on the waiting list and compared using z-tests. A 1-sided test was used to compare death rates; 2-sided tests were used to compare transplant rates. Overall and subgroup analyses were performed for demographic, geographic, and medical strata. In Era 2, we observed a 12% reduction in new liver transplant waiting list registrations, with the largest reductions seen in new registrants with low MELD/PELD scores. In Era 2, there was a 3.5% reduction in waiting list death rate (P = .076) and a 10.2% increase in cadaveric transplants (P < .001). The reduction in waiting list mortality and increase in transplantation rates were evenly distributed across all demographic and medical strata, with some variation across geographic variables. Early patient and graft survival after deceased donor liver transplantation remains unchanged. In conclusion, by eliminating the categorical waiting list prioritization system that emphasized time waiting, the new system has been associated with reduced registrations and improved transplantation rates without increased mortality rates for individual groups of waiting candidates or changes in early transplant survival rates.

AB - Liver allocation policy in the U.S. was recently changed to a continuous disease severity scale with minimal weight given to time waiting in an effort to better prioritize deceased donor liver transplant candidates. We compared rates of waiting list registrations, removals, transplants, and deaths during the year prior to implementation of the new liver allocation policy (2/27/01-2/26/02, Era 1) with the first year's experience (2/27/02-2/26/03, Era 2) under this new policy. Rates were adjusted for 1,000 patient years on the waiting list and compared using z-tests. A 1-sided test was used to compare death rates; 2-sided tests were used to compare transplant rates. Overall and subgroup analyses were performed for demographic, geographic, and medical strata. In Era 2, we observed a 12% reduction in new liver transplant waiting list registrations, with the largest reductions seen in new registrants with low MELD/PELD scores. In Era 2, there was a 3.5% reduction in waiting list death rate (P = .076) and a 10.2% increase in cadaveric transplants (P < .001). The reduction in waiting list mortality and increase in transplantation rates were evenly distributed across all demographic and medical strata, with some variation across geographic variables. Early patient and graft survival after deceased donor liver transplantation remains unchanged. In conclusion, by eliminating the categorical waiting list prioritization system that emphasized time waiting, the new system has been associated with reduced registrations and improved transplantation rates without increased mortality rates for individual groups of waiting candidates or changes in early transplant survival rates.

UR - http://www.scopus.com/inward/record.url?scp=0842346309&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0842346309&partnerID=8YFLogxK

U2 - 10.1002/lt.20024

DO - 10.1002/lt.20024

M3 - Article

C2 - 14755772

AN - SCOPUS:0842346309

VL - 10

SP - 7

EP - 15

JO - Liver Transplantation

JF - Liver Transplantation

SN - 1527-6465

IS - 1

ER -